Theravance Biopharma Inc (TBPH) FY2025Q4 Earning Prediction
Theravance Biopharma Inc (TBPH) is set to release its earnings performance on 02/26 16:05:00 ET in After Hours trading. Consensus forecasts predict a revenue of 46.22M and an earnings per share (EPS) of 0.35 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
TBPH Transcript
The earnings call highlighted strong financial performance with YUPELRI's sales growth and a robust cash position. The company's strategic focus on the CYPRESS study and potential ampreloxetine launch is promising, despite some regulatory risks. The Q&A revealed confidence in study design and operational execution, with analysts showing interest in future capital returns and pipeline evaluations. Overall, the positive financial metrics, strategic milestones, and optimistic outlook outweigh the risks, suggesting a positive stock price movement.
The earnings call summary indicates strong financial performance, with significant growth in hospital volume, collaboration revenue, and a solid cash position. The Q&A section reveals management's strategic focus on improving YUPELRI's channel mix and addressing payer perspectives for ampreloxetine. Despite some uncertainties in the timeline and pricing, overall sentiment remains positive due to strong revenue growth and financial health. The lack of market cap data suggests a moderate reaction, leading to a 'Positive' prediction for stock price movement.
The earnings call presents a mixed picture: strong YUPELRI sales growth and potential milestone payments are positive, but financial risks and supply chain challenges could dampen enthusiasm. The Q&A section reveals some uncertainty about hospital performance and regulatory timelines, which tempers optimism. Despite the company's commitment to shareholder returns, the lack of clear guidance on certain issues and typical seasonality concerns suggest a cautious market reaction, leading to a neutral sentiment.
TBPH Slides
TBPH Report
Frequently Asked Questions
What is the Theravance Biopharma Inc FY2025Q4 Earnings Release Date and Time?
Theravance Biopharma Inc (TBPH) is scheduled to release its FY2025Q4 earnings report onFeb 26, 2026, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Theravance Biopharma Inc FY2025Q4 Revenue and EPS?
Analysts' consensus predicts 46.22M in revenue and an EPS of 0.35 for Theravance Biopharma Inc's FY2025Q4.
What Does Intellectia's AI Predict for Theravance Biopharma Inc FY2025Q4 Earnings?
Intellectia's exclusive AI algorithms forecast a forTheravance Biopharma Inc's FY2025Q4 earnings, with a prediction date of Feb 26, 2026. Theravance Biopharma Inc
How Can I Use This Earnings Prediction to Trade TBPH Stock?
Leverage Intellectia's AI forecast to position trades ahead of theFeb 26, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Theravance Biopharma Inc FY2025Q4?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
